CompletedNot Applicable

The Effect of Metacognition-based, Manualized Intervention on Fear of Cancer Recurrence

Hong Kong177 participantsStarted 2021-07-21

Plain-language summary

The primary aim of this study is to assess the effect of ConquerFear, a metacognition-based manualized intervention on fear of cancer recurrence, using the randomized controlled trial approach, among Chinese patients newly diagnosed with curable cancer. This study aims to (1) test the direct effect of ConquerFear intervention on fear of cancer recurrence and on maladaptive metacognition, and (2) to test the indirect effect of ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with non-metastatic breast cancer, gynecologic cancer, or colorectal cancer
✓. had surgery as a primary treatment
✓. have had completed hospital-based adjuvant treatments including radiotherapy and chemotherapy within the past 18 months
✓. with the cut-off scored ≥ 13 on Severity, the subscale of Fear of cancer inventory
✓. are able to read and write Chinese
✓. are over the age of 18 years

Exclusion criteria

✕. non-Chinese ethnicity
✕. Patients diagnosed with metastatic cancer
✕. with a current diagnosis of depression or psychosis
✕. currently receiving psychological treatment
✕. with language difficulties or intellectual disability.

What they're measuring

Fear of cancer recurrence

Timeframe: Baseline, immediate post-intervention, 3months post-intervention, and 6months post-intervention

Trial details

NCT IDNCT04568226

SponsorThe University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-30

View on ClinicalTrials.gov More Fear of Cancer Recurrence trials